REGISTERED NUMBER: 01087755 (England and Wales)

STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

NATIONAL UNPLANNED PREGNANCY

ADVISORY SERVICE LIMITED

Page

Company Information

1

Strategic Report

2

Report of the Directors

4

Report of the Independent Auditors

6

Income Statement

10

Other Comprehensive Income

11

Balance Sheet

12

Statement of Changes in Equity

13

Cash Flow Statement

14

Notes to the Cash Flow Statement

15

Notes to the Financial Statements

16

DIRECTORS:

Ms K Devonport

A Flaherty

REGISTERED OFFICE:

5 Arthur Road

Edgbaston

Birmingham

B15 2UL

REGISTERED NUMBER:

01087755 (England and Wales)

AUDITORS:

GBJ Financial Limited

Statutory Auditor

Sterling House

27 Hatchlands Road

Redhill

Surrey

RH1 6RW

The directors present their strategic report for the year ended 31 March 2025.

The National Unplanned Pregnancy Advisory Service (NUPAS) is a UK-based independent healthcare provider regulated by the Care Quality Commission and licensed by the Department of Health and Social Care. NUPAS operates in the highly sensitive and strictly regulated Abortion Services sector with a heavy focus on family planning and sexual health services.

Our aim is to provide information, treatment, and choices to enable people to make informed decisions when faced with an unplanned pregnancy. Our strategic framework is bringing focus and pace to our efforts as we respond to ever-changing landscapes and advances in information technology infrastructure, data and digital, as well as evolving regulatory environments. We operate a highly localised service model in community-based locations across the UK ensuring equitable access to services for all.

The National Unplanned Pregnancy Advisory Service (NUPAS) is a UK-based independent healthcare provider, regulated by the Care Quality Commission and licensed by the Department of Health and Social Care. NUPAS operates within the highly regulated and sensitive Abortion Services sector, with a strong focus on family planning and sexual health services.

NUPAS' core purpose is to provide high-quality information, treatment, and choice, enabling individuals to make informed decisions when faced with an unplanned pregnancy. Our strategic framework continues to provide clarity, focus, and momentum as we respond to evolving service demands, advances in information technology, data and digital infrastructure, and changes within the regulatory environment.

The Organisation delivers a highly localised, community-based service model across the UK, ensuring equitable access to care regardless of geography or circumstance.

Strong governance remains central to NUPAS' performance and its ability to grow safely and sustainably. The Board of Directors is supported by the Senior Leadership Team, which is informed by a range of clinical and non-clinical committees. These committees oversee all aspects of service delivery, governance, and the audit of clinical outcomes. Quality outcomes are measured against regulatory standards and recognised best-practice guidelines across all areas of operation. Regular engagement with patients, employees, and commissioners provides valuable feedback, enabling the Organisation to continuously review performance and implement improvements where required.

NUPAS works collaboratively with statutory regulatory bodies and partner organisations to safeguard children and adults in accordance with local policies and procedures. In addition to its established working relationships with the NHS at national, regional, and local levels, the Organisation collaborates closely with primary care providers, local authorities, charitable organisations, and other non-NHS agencies across the UK.

For the period ended 31 March 2025, the Directors are pleased to report that NUPAS achieved all of its quality and financial objectives, supporting more individuals than ever before.

Although NUPAS is privately owned it has never paid dividends and instead chooses to generate any surplus into the Organisation, its services, and its workforce. NUPAS is also proud to have made charitable donations to a number of organisations supporting vulnerable individuals within the communities it serves.

The Organisation continues to grow both in the number of people it supports and in its workforce. Staff retention rates have reached their highest levels to date, and patient feedback remains consistently excellent. NUPAS' ongoing commitment to supporting, developing, and retaining exceptional staff has reinforced its reputation as an employer of choice within Abortion Services.

Regulatory feedback throughout the year has remained consistently positive across the Organisation. NUPAS continues to welcome inspections from the Care Quality Commission and values the opportunity to demonstrate the high standard of care delivered by its staff.

During 2024/2025, significant investment was made in the development of new surgical centres and the enhancement of existing facilities. This investment has expanded patient choice, improved patient experience, and strengthened service provision where a surgical pathway is clinically indicated. In parallel, the Organisation has continued to develop community-based Early Medical Abortion centres.

In 2025/2026, NUPAS plans to build on this progress by further expanding and enhancing surgical services in areas where provision can be improved.

ON BEHALF OF THE BOARD:

A Flaherty - Director

24 December 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

DIVIDENDS

No dividends will be distributed for the year ended 31 March 2025.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

Ms K Devonport

A Flaherty

POLITICAL DONATIONS AND EXPENDITURE

The company made total donations of £109,600, split between a number of local charities. No political donations were made.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are also responsible for the preparation of the Strategic Report.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:

A Flaherty - Director

24 December 2025

Opinion

We have audited the financial statements of National Unplanned Pregnancy Advisory Service Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. Owing to the inherent limitations of an audit, there is an unavoidable risk that material misstatements in the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We enquired of management concerning the Company's policies and procedures relating to:

- the identification, evaluation and compliance with laws and regulations;

- the detection and response to the risks of fraud; and

- the establishment of internal controls to mitigate risks related to fraud or non-compliance with laws and regulations.

The Company is subject to many laws and regulations where the consequences of non-compliance could have a material effect on amounts or disclosures in the financial statements. We identified the following laws and regulations as the most likely to have a material effect if non-compliance were to occur; United Kingdom Generally Accepted Accounting Practice, the Companies Act 2006, tax legislation, anti-bribery legislation, GDPR and employment law.

We assessed the susceptibility of the company's financial statements to material misstatement, including how fraud might occur, by evaluating management's incentives and opportunities for manipulation of the financial statements. This included the evaluation of the risk of management override of controls. We determined that the principal risks were in relation to:

- journal entries that increased revenues or that reclassified costs from the income statement to the balance sheet

- potential management bias in determining accounting estimates

- revenue recognition

- transactions with related parties.

It is the audit partner's assessment that the audit team collectively had the appropriate competence and capabilities to identify or recognise non-compliance with laws and regulations.

We obtained an understanding of the Company's operations, including the nature of its revenue sources, products and services and of its objectives and strategies to understand the classes of transactions, account balances, expected financial statement disclosures and business risks that may result in risks of material misstatement. We also considered the effectiveness of the Company's control environment to identify and prevent any irregularities and fraud.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Jonathan Hillier (Senior Statutory Auditor)

for and on behalf of GBJ Financial Limited

Statutory Auditor

Sterling House

27 Hatchlands Road

Redhill

Surrey

RH1 6RW

24 December 2025

TURNOVER

14,783,452

13,780,139

Cost of sales

10,299,384

9,747,210

GROSS PROFIT

4,484,068

4,032,929

Administrative expenses

3,463,624

3,597,718

OPERATING PROFIT

4

1,020,444

435,211

Interest receivable and similar income

32,342

24,923

1,052,786

460,134

Interest payable and similar expenses

5

115,917

33,075

PROFIT BEFORE TAXATION

936,869

427,059

Tax on profit

6

259,902

106,261

PROFIT FOR THE FINANCIAL YEAR

676,967

320,798

PROFIT FOR THE YEAR

676,967

320,798

OTHER COMPREHENSIVE INCOME

Fixed asset revaluation

(1,198,000

)

-

Income tax relating to other comprehensive income

-

-

OTHER COMPREHENSIVE INCOME FOR THE YEAR, NET OF INCOME TAX

(1,198,000

)

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

(521,033

)

320,798

FIXED ASSETS

Tangible assets

7

6,752,234

7,302,057

Investments

8

4,857

4,857

6,757,091

7,306,914

CURRENT ASSETS

Stocks

9

117,860

103,428

Debtors

10

2,061,608

2,298,870

Cash at bank and in hand

3,029,291

2,533,911

5,208,759

4,936,209

CREDITORS

Amounts falling due within one year

11

2,591,124

3,020,264

NET CURRENT ASSETS

2,617,635

1,915,945

TOTAL ASSETS LESS CURRENT LIABILITIES

9,374,726

9,222,859

CREDITORS

Amounts falling due after more than one year

12

(1,057,815

)

(382,000

)

PROVISIONS FOR LIABILITIES

14

(76,812

)

(79,727

)

NET ASSETS

8,240,099

8,761,132

CAPITAL AND RESERVES

Called up share capital

15

8,272

8,272

Share premium

16

84,302

84,302

Revaluation reserve

16

3,501,589

4,699,589

Retained earnings

16

4,645,936

3,968,969

SHAREHOLDERS' FUNDS

8,240,099

8,761,132

The financial statements were approved by the Board of Directors and authorised for issue on 24 December 2025 and were signed on its behalf by:

A Flaherty - Director

Ms K Devonport - Director

Called up

share

Retained

Share

Revaluation

Total

capital

earnings

premium

reserve

equity

£

£

£

£

£

Balance at 1 April 2023

8,272

3,648,171

84,302

4,699,589

8,440,334

Changes in equity

Total comprehensive income

-

320,798

-

-

320,798

Balance at 31 March 2024

8,272

3,968,969

84,302

4,699,589

8,761,132

Changes in equity

Total comprehensive income

-

676,967

-

(1,198,000

)

(521,033

)

Balance at 31 March 2025

8,272

4,645,936

84,302

3,501,589

8,240,099

Cash flows from operating activities

Cash generated from operations

1

865,860

(62,966

)

Interest paid

(115,917

)

(33,075

)

Tax paid

(112,955

)

(134,847

)

Net cash from operating activities

636,988

(230,888

)

Cash flows from investing activities

Purchase of tangible fixed assets

(186,533

)

(550,963

)

Sale of tangible fixed assets

12,583

19,700

Interest received

32,342

24,923

Net cash from investing activities

(141,608

)

(506,340

)

Increase/(decrease) in cash and cash equivalents

495,380

(737,228

)

Cash and cash equivalents at beginning of year

2

2,533,911

3,271,139

Cash and cash equivalents at end of year

2

3,029,291

2,533,911

1.	RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025

2024

£

£

Profit before taxation

936,869

427,059

Depreciation charges

319,940

291,982

Profit on disposal of fixed assets

(2,933

)

(3,350

)

Finance costs

115,917

33,075

Finance income

(32,342

)

(24,923

)

1,337,451

723,843

Increase in stocks

(14,432

)

(19,863

)

Decrease/(increase) in trade and other debtors

237,262

(1,078,837

)

(Decrease)/increase in trade and other creditors

(694,421

)

311,891

Cash generated from operations

865,860

(62,966

)

2.	CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025

31.3.25

1.4.24

£

£

Cash and cash equivalents

3,029,291

2,533,911

Year ended 31 March 2024

31.3.24

1.4.23

£

£

Cash and cash equivalents

2,533,911

3,271,139

3.	ANALYSIS OF CHANGES IN NET FUNDS

At 1.4.24

Cash flow

At 31.3.25

£

£

£

Net cash

Cash at bank and in hand

2,533,911

495,380

3,029,291

2,533,911

495,380

3,029,291

Debt

Finance leases

-

(791,234

)

(791,234

)

-

(791,234

)

(791,234

)

Total

2,533,911

(295,854

)

2,238,057

1.	STATUTORY INFORMATION

National Unplanned Pregnancy Advisory Service Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Related party exemption

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

2% on cost

Long leasehold

-

2% on cost

Plant and machinery

-

25% on reducing balance

Office equipment and furniture

-

15% on reducing balance

Computer equipment

-

15% on reducing balance

In accordance with FRS 15 the aggregate surplus or deficit on revaluation of properties is transferred to the revaluation reserve. When properties are sold the cumulative gains or losses previously recognised in reserves are recycled through the profit and loss account for the current period. Any unrealised losses in value below original cost are charged to the profit and loss account.

Depreciation is not charged on freehold or leasehold properties as these are maintained to a very high standard as required by the Department of Health and the Care Quality Commission. As the residual value is close to the carrying value, any depreciation would be immaterial. Annual impairment reviews are performed in accordance with FRS 11. The directors consider that this accounting policy results in the financial statements showing a true and fair view.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits

The company operates money purchase pension schemes. Contributions payable to pension schemes are charged to the profit and loss account in the period in which payment is made.

Group accounts

The company has not prepared consolidated accounts on the basis that the dormant subsidiaries are not material for the purpose of giving a true and fair view as defined by s405 (2) of the Companies Act 2006.

Leases

At inception, the company assesses whether a contract is, or contains, a lease within the scope of IFRS 16. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Where a tangible asset is acquired through a lease, the company recognises a right-of-use asset and a lease liability at the lease commencement date. Right-of-use assets are included within property, plant and equipment, apart from those that meet the definition of investment property.

The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date plus any initial direct costs and an estimate of the cost of obligations to dismantle, remove, refurbish or restore the underlying asset and the site on which it is located, less any lease incentives received.

The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The estimated useful lives of right-of-use assets are determined on the same basis as those of other property, plant and equipment. The right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

The lease liability is initially measured at the present value of the lease payments that are unpaid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the company's incremental borrowing rate. Lease payments included in the measurement of the lease liability comprise fixed payments, variable lease payments that depend on an index or a rate, amounts expected to be payable under a residual value guarantee, and the cost of any options that the company is reasonably certain to exercise, such as the exercise price under a purchase option, lease payments in an optional renewal period, or penalties for early termination of a lease.

The lease liability is measured at amortised cost using the effective interest method. It is remeasured when there is a change in: future lease payments arising from a change in an index or rate; the company's estimate of the amount expected to be payable under a residual value guarantee; or the company's assessment of whether it will exercise a purchase, extension or termination option. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.

The company has elected not to recognise right-of-use assets and lease liabilities for short-term leases of machinery that have a lease term of 12 months or less, or for leases of low-value assets including IT equipment. The payments associated with these leases are recognised in profit or loss on a straight-line basis over the lease term.

3.	EMPLOYEES AND DIRECTORS

2025

2024

£

£

Wages and salaries

7,245,849

6,314,993

Social security costs

792,801

658,824

Other pension costs

252,711

381,514

8,291,361

7,355,331

The average number of employees during the year was as follows:

2025

2024

Nursing staff

82

67

Other staff

105

94

187

161

2025

2024

£

£

Directors' remuneration

274,703

256,530

Directors' pension contributions to money purchase schemes

15,000

81,321

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes

2

2

Information regarding the highest paid director is as follows:

2025

2024

£

£

Emoluments etc

152,686

132,835

Pension contributions to money purchase schemes

10,000

40,000

4.	OPERATING PROFIT

The operating profit is stated after charging/(crediting):

2025

2024

£

£

Depreciation - owned assets

319,940

291,981

Profit on disposal of fixed assets

(2,933

)

(3,350

)

Auditors' remuneration

18,950

18,750

Auditors' remuneration for non audit work

650

-

5.

INTEREST PAYABLE AND SIMILAR EXPENSES

2025

2024

£

£

Lease interest

82,842

-

Loan interest

33,075

33,075

115,917

33,075